The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of occlusion is listed in the rx acculink carotid stent system instructions for use as a possible adverse event associated with the use of this device.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|
It was reported that the procedure was to treat a heavily tortuous, heavily calcified right external common carotid artery.On (b)(6) 2021, an acculink stent was successfully deployed.The next day, on (b)(6) 2021, the patient showed signs of hyperperfusion (unknown if blood pressure was too high or too low).The patient's blood pressure was medically managed (patient remained under observation but condition remained relatively stable and no treatment was performed).Then on (b)(6) 2021, imaging and ultra sound showed 70% occlusion.The surgeon decided to surgically remove the stent and treat the occlusion via a carotid surgical endarterectomy intervention.Hospitalization was prolonged but patient condition was fine after surgical procedure.No additional information was provided.
|